Company: BLNE
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001641172-25-024044
Chunk: 28

Company: Beeline Holdings, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 8
Chunk 28
---
12, 2025, the Company implemented a 1-for-10 reverse stock split of its common stock. All share and per share data in these consolidated
financial statements have been retrospectively adjusted to give effect to the stock split.

From
June 26, 2025 through June 30, 2025, certain holders of the Notes converted $1.0 million of their Notes into 747,221 shares of common
stock.

In
June 2025, the Company issued 10,000 shares of common stock in satisfaction of the former Chief Executive Officer’s employment
agreement which was recorded as stock issuable of $14,300 as of March 31, 2025.

In
February 2025, the Company issued 13,115 shares of common stock related to a legal settlement agreed upon in October 2024 where $0.1
million was recorded as stock to be issued as of December 31, 2024.

During
2025, the Company sold 5,540,043 shares of common stock for gross proceeds of $7.0 million in at-the-market public placements. The Company recorded related offering costs of $0.3 million as of June
30, 2025.

During 2025, the
Company issued a cumulative 6,564,947 shares of common stock as a result of various preferred stock conversions as noted below.

During
the six months ended June 30, 2024, the Company issued 176
shares of common stock to a director for stock-based compensation
of $2,046
at $11.60 per share. During the six months ended
June 30, 2024, the Company issued 5,574
shares of common stock to employees and a consultant for stock-based
compensation of $0.1
million at $12.10
per share.

ELOC
Agreement

On
December 31, 2024, the Company entered into entered into a Common Stock Purchase Agreement and related Registration Rights Agreement
(collectively, the “ELOC Agreement”) with an institutional investor (the “Purchaser”) pursuant to which the Company
agreed to sell, and the Purchaser agreed to purchase, up to $35 million of the Company’s common stock, subject to a sale limit
of 19.99% of the outstanding shares of the Company’s common stock.

On
March 7, 2025, the Company entered into an Amended E